The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. - sprookjes - yvandenbroek - TriplyDB

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

http://www.wikidata.org/entity/Q34614340

about

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update How grim is hepatocellular carcinoma?Nodule in Liver: Investigations, Differential Diagnosis and Follow-up Radiological diagnosis of hepatocellular carcinoma Management of hepatocellular carcinoma: An update Hepatocellular carcinoma: a review Diagnostic and Therapeutic Approaches to Hepatocellular Carcinoma: Understanding the Barcelona Clínic Liver Cancer Protocol Update in management of hepatocellular carcinoma in Eastern population Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine Recent advances in the imaging of hepatocellular carcinoma Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.Characterization of Focal Liver Lesions Indistinctive on B Mode Ultrasound: Benefits of Contrast-Enhanced Ultrasound Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study.Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Hepatocellular carcinoma: clinical frontiers and perspectives.Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI.Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area.Hepatocellular carcinoma: natural history, current management, and emerging tools.MRI of Focal Liver Lesions.Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics Update on new approaches in the management of hepatocellular carcinoma.

P2860

Q24635267-CFB5CB15-866E-4271-B53A-D4B99255AC40 Q26770020-DBCD9B01-5204-4C5B-B0AA-7C652ACA713F Q26771246-572218CE-D1EA-4D59-A314-45D09AB860B7 Q26822764-0FCE0645-B7BA-4644-B6CD-A9EC0E044D9D Q26825172-0E70872C-4903-4218-BB6D-63D700F36234 Q27001669-A6A14836-03AA-46A7-8CB6-0CFD184B95A0 Q27015959-F640FEB3-0186-4525-9FBE-A476CF67E2CC Q27027683-D2CE307E-0F7D-4F5F-ACF5-2D88D1A33C3F Q27860530-193CB5E2-1027-4980-8E9C-D98314ADEF26 Q28069290-BF790F5E-4257-41DA-965A-64906E3BA427 Q28071608-9665CE91-5C2E-4575-8E57-92C17510EA74 Q28080480-902F2711-F479-4A15-9293-7CEA1279C214 Q28087569-F78AFD56-29A7-405B-81C9-8D6DFBF08854 Q30415186-5DC61C08-E33B-4953-A65B-4861E8335BFE Q30436747-0BA03273-0919-4A20-A917-3D3C2AE8BF34 Q30448049-1AA2CE83-F791-4552-992D-908B20E0C80B Q30837374-7B7B3D72-1792-4148-BC96-4257EEB8F13C Q33436257-EA955996-F522-43C3-BB95-1EF34FABD09C Q33561375-F4F091BE-B640-46A2-B866-8522FA2531D7 Q33604041-9E8DB8CD-9D97-40CF-AC40-DBB29F9747C8 Q33686038-608BB13B-1B70-4728-8002-71753BA40F66 Q33818674-1F0CACA4-2571-44DA-9CB3-42EC8346B48A Q33974776-5437107A-4DE8-401E-BD72-5FDA8D38F2F9 Q34657257-41063283-838C-46C2-8C38-2F98F3FBC228 Q34675546-BAF37B65-32F3-40D9-BDB5-9D7D5E6CF582 Q34682228-B791DDE5-4E6B-47BD-8750-345C195C2F04 Q34826535-8FEF2B62-D825-4D0B-9932-69AABC883550 Q35112053-655B52B3-A8CC-4B41-A981-5E646D513E6C Q35148664-08C77AC3-4C92-498A-88B1-E5ADB67F0A9C Q35207736-319A7851-74AC-473F-BD3F-DBDCA9C16552 Q35824096-4AC19BF3-0C60-4591-8588-BD7B40F47EE7 Q36153984-2EEFBA22-41CE-4A14-92BD-55D80EDE2D6B Q36171275-A19DE791-1717-4E3F-B3AB-579A198F27ED Q36291622-D570999A-6300-4705-BE0A-22FDACF2FF68 Q36325824-4ABFBF4D-CD1F-48CC-B78F-942AD04ADC5B Q36423114-F65FC609-50C0-45A9-9A1B-BB14FDE1A27F Q37000692-45096EF7-EB9C-4A65-8349-DF6D66B338DD Q37072699-DD0D5262-955F-47DB-A9BC-94E2E627D560 Q37355835-9930A777-604E-40AA-82B7-71D38F86AB2D Q37356150-FFC1F84E-0BB9-4E70-98C7-F2E0010D63FC

P2860

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

http://www.wikidata.org/entity/Q34614340

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@ast

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@en

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@nl

type

label

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@ast

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@en

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@nl

prefLabel

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@ast

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@en

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@nl

P1433

Q34614340-136497A8-0F53-42B8-91A9-307EE094A517

P1476

Q34614340-AA2F53A4-BE6E-4E7B-BD6B-3480A662E324

P2093

Q34614340-1A9B7C91-E1B3-40D9-93A0-BC678DCFFC1A

Q34614340-2A7C796C-43A4-41A0-B5C9-79ED95A06E36

Q34614340-2B345A59-BE47-4F85-9757-A028A2B5528E

Q34614340-394F38CE-16F9-4F93-8800-1AA27961B842

Q34614340-4AF67A58-07F7-44AE-AF1F-BADF6FAF20F9

Q34614340-563E4F23-31E7-4D1A-B805-7E7B1A83BB7A

Q34614340-6A808AB2-EEC1-4B26-91E8-691202A1A7B4

Q34614340-7DA3FF77-40F0-4304-8F55-CECAEF4CFEAB

Q34614340-9C22E96C-BD69-495A-A39E-CD0D3C7695FD

Q34614340-A72DFDA5-AC9F-405F-B02E-244BACAC414D

P304

Q34614340-A56593CB-1599-495D-B0EC-ADE9EFC7F330

P31

Q34614340-A5A611DD-56F9-490D-9E52-DF7476CE0D38

P356

Q34614340-8CF20F5A-9730-410D-B6EE-3E5BF02DF35A

P407

Q34614340-A548393E-6247-42F3-8513-A4153B8CD2EB

P433

Q34614340-4D1B9897-6B67-4745-A4D5-349641FB6B95

P478

Q34614340-C203BD6A-275C-467F-AE3B-41C1AA82A2AB

P577

Q34614340-4FCB50BB-3841-4D5D-9B1C-E9FDC93F0416

P698

Q34614340-FE480091-C1A3-4271-846D-E012321C3DC2

P921

Q34614340-72244cb2-ddc4-445b-98fc-718372f648a0

Q34614340-B9CF3F78-B0E8-4901-A64F-2DE7B15CAA9C

P356

GUT.2009.187286

P1433

P1476

The diagnostic and economic im ...... llular carcinoma in cirrhosis.

@en

P2093

Angelo Sangiovanni

http://www.w3.org/2001/XMLSchema#string

Cristina Della Corte

http://www.w3.org/2001/XMLSchema#string

Guido Ronchi

http://www.w3.org/2001/XMLSchema#string

Laura V Forzenigo

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Rumi

http://www.w3.org/2001/XMLSchema#string

Massimo Colombo

http://www.w3.org/2001/XMLSchema#string

Massimo Iavarone

http://www.w3.org/2001/XMLSchema#string

Matteo A Manini

http://www.w3.org/2001/XMLSchema#string

Mirella Fraquelli

http://www.w3.org/2001/XMLSchema#string

Piero Biondetti

http://www.w3.org/2001/XMLSchema#string

P304

638-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2009.187286

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19951909

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis